Donor-Derived Infections: Approach and Management
Donor-Derived Infections: Approach and Management
Learn about the factors to consider during the evaluation of a deceased donor, recommendations, and emerging novel deceased donor populations.
- 2:00 PM - 3:00 PM EST
- Virtual, as part of AST's T3 webinar series.
Objectives:
After participating in this webinar, the attendee will be able to:
- Describe the epidemiology of donor derived infections (consider 10-year DTAC review and other DTAC studies).
- Outline the factors to consider during the evaluation of a deceased donor with suspected or proven infection.
- Understand changes to PHS risk definitions and recommendations.
- Describe the emerging novel deceased donor populations (SARS-CoV-2 NAT+, HBsAg+ & HBV DNA+, and Monkeypox).
Speakers:
- Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA, FAST • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
- Marian Michaels, MD, MPH, FAST • Professor of Pediatrics and Surgery, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA
Moderator:
- Ricardo La Hoz, MD, FACP, FIDSA, FAST • Associate Professor of Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX
The AST Education Committee would like to thank the Infectious Disease Community of Practice (IDCOP) for suggesting this topic as part of the 2022-2023 T3 webinar series. Learn more about AST's COPs at www.www.myast.org/cops.
Advertisements
This content was developed independently by AST and supported by a financial contribution from
